Edition:
United States

People: Depomed Inc (DEPO.O)

DEPO.O on Nasdaq

10.51USD
24 Jul 2017
Change (% chg)

$-0.09 (-0.85%)
Prev Close
$10.60
Open
$10.58
Day's High
$10.78
Day's Low
$10.20
Volume
2,241,108
Avg. Vol
1,624,881
52-wk High
$27.02
52-wk Low
$9.38

Moretti, August 

Mr. August J. Moretti is Chief Financial Officer and Senior Vice President of Depomed Inc. From 2004 to December 2011, Mr. Moretti served as Chief Financial Officer and Senior Vice President of Alexza Pharmaceuticals, Inc., a publicly-held pharmaceutical company. From 2001 to 2004, Mr. Moretti served as Chief Financial Officer of Alavita, Inc. (formerly Surromed, Inc.), a privately-held biotechnology company. Prior to Alavita, Mr. Moretti was a partner of Heller Ehrman LLP, an international law firm. Mr. Moretti holds a B.A. from Princeton University and a J.D. from Harvard Law School.

Basic Compensation

Total Annual Compensation, USD 418,820
Restricted Stock Awards, USD 602,625
Long-Term Incentive Plans, USD --
All Other, USD 784,014
Fiscal Year Total, USD 1,805,460

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 8,297 71,744.00